Skip to main content

Table 1 Clinicopathological characteristics of HCC patients according to PPP1R26 expression

From: PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition

Variables

PPP1R26-negative (n = 31)

PPP1R26-positive (n = 97)

P-value

Sex

 Male

28

83

0.497

 Female

3

14

 

Age (years)

  ≤ 60

23

63

0.34

 >60

8

34

 

Tumor size (cm)

  ≤ 5

19

50

0.343

 >5

12

47

 

Tumor number

 Single

27

77

0.338

 Multiple

4

20

 

Microscopic vascular invasion

 Absent

29

66

0.005

 Present

2

31

 

AFP (ng/ml) a

  ≤ 200

22

62

0.375

 >200

8

34

 

Cirrhosisa

 Negative

18

65

0.327

 Positive

13

31

 

HBVa

 Negative

5

21

0.67

 Positive

26

75

 

HCV

 Negative

30

92

0.658

 Positive

1

5

 

Edmondson-Steiner grade

 1,2

24

77

0.816

 3,4

7

20

 

BCLC stage

 0 or A

25

55

0.017

 B

4

11

 

 C

2

31

 
  1. aData for AFP, cirrhosis, HBV were missing for two, one and one patients, respectively